Y-Intercept (Hong Kong) Ltd

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1772875 HONG KONG, K3

Position in ADPT

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$2,898,688

+$2,512,550 QoQ

Shares Held

135,137

+468.4% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

of 18 holders

Holding Since

Dec 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $30,838,073 across 12 Diagnostics & Research names. ADPT ranks #4 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IDXX	Idexx Laboratories Inc /De	16,330	$8,596,765
2	GH	Guardant Health, Inc.	52,547	$7,883,626
3	ILMN	Illumina, Inc.	18,655	$3,280,108
4	ADPT	Adaptive Biotechnologies Corp This page	135,137	$2,898,688
5	IQV	Iqvia Holdings Inc.	10,950	$2,115,759
6	WGS	GeneDx Holdings Corp.	27,521	$1,889,316
7	TMO	Thermo Fisher Scientific Inc.	2,669	$1,338,129
8	LH	Labcorp Holdings Inc.	4,074	$1,140,720

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,898,688	135,137	+468.4%	Shares	Sole	2026-07-14
2025-12-31	$386,138	23,777	-64.6%	Shares	Sole	2026-02-13
2024-06-30	$243,452	67,252	+267.3%	Shares	Sole	2024-08-14
2023-06-30	$122,860	18,310	-32.5%	Shares	Sole	2023-08-14
2023-03-31	$239,522	27,126	+82.3%	Shares	Sole	2023-05-09
2022-03-31	$206,478	14,876	+85.0%	Shares	Sole	2022-05-16
2021-03-31	$323,690	8,040	+83.0%	Shares	Sole	2021-05-12
2020-12-31	$259,758	4,393	—	Shares	Sole	2021-02-05
No filing history on record for this holder in this stock.